Targeting HER2-positive breast cancer: advances and future directions
Last Updated: Friday, July 17, 2026
This review article highlights the current treatment landscape for HER2+ breast cancer, mechanisms of HER2-targeted resistance, next-generation therapies, and the potential benefits of harnessing the immune system to treat HER2+ breast cancer.